Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma

References

• Mosconi S, Beretta GD, Labianca R, et al. Cholangiocarcinoma. Critic Rev Oncol Hematol. 2009;69(3):259–270.
   PubMed Web of Science ®Google Scholar
• Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13(5):261–280.
   PubMed Web of Science ®Google Scholar
• Khan SA, Davidson BR, Goldin RD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61(12):1657–1669.
   PubMed Web of Science ®Google Scholar
• Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 2015;29(2):221–232.
   PubMed Web of Science ®Google Scholar
• Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol. 2013;11(1):13–21.e1.
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York (NY): Springer Verlag; 2010.
   Google Scholar
• Rizvi S, Khan SA, Hallemeier CL, et al. Cholangiocarcinoma – evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2017;15:95–111.
   PubMed Web of Science ®Google Scholar
• Valle JW, Lamarca A, Goyal L, et al. New horizons for precision medicine in biliary tract cancers. Cancer Discov. 2017;7(9):943–962.
   PubMed Web of Science ®Google Scholar
• Byrling J, Andersson B, Marko-Varga G, et al. Cholangiocarcinoma – current classification and challenges towards personalised medicine. Scand J Gastroenterol. 2016;51(6):641–643.
   PubMed Web of Science ®Google Scholar
• Park JE, Lenter MC, Zimmermann RN, et al. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999;274(51):36505–36512.
   PubMed Web of Science ®Google Scholar
• Puré E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018;37(32):4343–4357.
   PubMed Web of Science ®Google Scholar
• Gascard P, Tlsty TD. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev. 2016;30(9):1002–1019.
   PubMed Web of Science ®Google Scholar
• Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582–598.
   PubMed Web of Science ®Google Scholar
• Liu F, Qi L, Liu B, et al. Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis. PLoS One. 2015;10(3):e0116683.
   PubMed Web of Science ®Google Scholar
• Zi F, He J, He D, et al. Fibroblast activation protein alpha in tumor microenvironment: recent progression and implications (review). Mol Med Rep. 2015;11(5):3203–3211.
   PubMed Web of Science ®Google Scholar
• Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. Geneva, Switzerland: World Health Organization; International Agency for Research on Cancer; 2010.
   Google Scholar
• Markov P, Satoi S, Kon M. Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2016;23(9):523–532.
   PubMed Web of Science ®Google Scholar
• Puram SV, Tirosh I, Parikh AS, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171(7):1611–1624.e24.
   PubMed Web of Science ®Google Scholar
• Shi M, Yu DH, Chen Y, et al. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J Gastroenterol. 2012;18(8):840–846.
   PubMed Web of Science ®Google Scholar
• Ogłuszka M, Orzechowska M, Jędroszka D, et al. Evaluate cutpoints: adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator. Comput Methods Program Biomed. 2019;177:133–139.
   PubMed Web of Science ®Google Scholar
• Altman DG, McShane LM, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med. 2012;9(5):e1001216.
   PubMed Web of Science ®Google Scholar
• McShane LM, Altman DG, Sauerbrei W, et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93(4):387–391.
   PubMed Web of Science ®Google Scholar
• Brivio S, Cadamuro M, Strazzabosco M, et al. Tumor reactive stroma in cholangiocarcinoma: the fuel behind cancer aggressiveness. World J Hepatol. 2017;9(9):455–468.
   PubMed Web of Science ®Google Scholar
• Cadamuro M, Stecca T, Brivio S, et al. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. Biochim Biophys Acta. 2017;1864:1435–1443.
   Web of Science ®Google Scholar
• Chuaysri C, Thuwajit P, Paupairoj A, et al. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Oncol Rep. 2009;21(4):957–969.
   PubMed Web of Science ®Google Scholar
• Okabe H, Beppu T, Hayashi H, et al. Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16(9):2555–2564.
   PubMed Web of Science ®Google Scholar
• Cortez E, Roswall P, Pietras K. Functional subsets of mesenchymal cell types in the tumor microenvironment. Semin Cancer Biol. 2014;25:3–9.
   PubMed Web of Science ®Google Scholar
• Yang X, Lin Y, Shi Y, et al. FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 2016;76(14):4124–4135.
   PubMed Web of Science ®Google Scholar
• Sha M, Jeong S, Qiu BJ, et al. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma. Cancer Med. 2018;7(9):4665–4677.
   PubMed Web of Science ®Google Scholar
• Busek P, Balaziova E, Matrasova I, et al. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma. Tumor Biol. 2016;37(10):13961–13971.
   PubMedGoogle Scholar
• Patsouras D, Papaxoinis K, Kostakis A, et al. Nicolopoulou-Stamati P. Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma. Mol Med Rep. 2015;11(6):4585–4590.
   PubMed Web of Science ®Google Scholar
• Kawase T, Yasui Y, Nishina S, et al. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma. BMC Gastroenterol. 2015;15(1):109.
   PubMed Web of Science ®Google Scholar
• Lo A, Li CP, Buza EL, et al. Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma. JCI Insight. 2017;2(19):pii: 92232. 
   Web of Science ®Google Scholar
• Yuan D, Liu B, Liu K, et al. Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma. J Surg Oncol. 2013;108(3):157–162.
   PubMed Web of Science ®Google Scholar
• Ding L, Ye L, Xu J, et al. Impact of fibroblast activation protein on osteosarcoma cell lines in vitro. Oncol Lett. 2014;7(3):699–704.
   PubMed Web of Science ®Google Scholar
• Mori Y, Kono K, Matsumoto Y, et al. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma. Oncology. 2004;67(5–6):411–419.
   PubMed Web of Science ®Google Scholar
• Goscinski MA, Suo Z, Florenes VA, et al. FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions. Ultrastruct Pathol. 2008;32(3):89–96.
   PubMed Web of Science ®Google Scholar
• Iwasa S, Okada K, Chen WT, et al. Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett. 2005;227(2):229–236.
   PubMed Web of Science ®Google Scholar
• Cao F, Wang S, Wang H, et al. Fibroblast activation protein-alpha in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways. Mol Med Rep. 2018;17(2):2593–2599.
   PubMed Web of Science ®Google Scholar
• Park SY, Kim HM, Koo JS. Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer. Breast Cancer Res Treat. 2015;149(3):727–741.
   PubMed Web of Science ®Google Scholar
• Kelly T, Kechelava S, Rozypal TL, et al. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod Pathol. 1998;11(9):855–863.
   PubMed Web of Science ®Google Scholar
• Jia J, Martin TA, Ye L, et al. FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway. BMC Cell Biol. 2014;15(1):16.
   PubMedGoogle Scholar
• Du H, Chen D, Zhou Y, et al. Fibroblast phenotypes in different lung diseases. J Cardiothorac Surg. 2014;9(1):147.
   PubMed Web of Science ®Google Scholar
• Wang H, Wu Q, Liu Z, et al. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis. 2014;5(4):e1155–e.
   PubMed Web of Science ®Google Scholar
• Zhang M, Xu L, Wang X, et al. Expression levels of seprase/FAPα and DPPIV/CD26 in epithelial ovarian carcinoma. Oncol Lett. 2015;10(1):34–42.
   PubMed Web of Science ®Google Scholar
• Mhawech-Fauceglia P, Yan L, Sharifian M, et al. Stromal expression of fibroblast activation protein alpha (FAP) predicts platinum resistance and shorter recurrence in patients with epithelial ovarian cancer. Cancer Microenviron. 2015;8(1):23–31.
   PubMed Web of Science ®Google Scholar
• Kahounova Z, Kurfurstova D, Bouchal J, et al. The fibroblast surface markers FAP, anti-fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial-to-mesenchymal transition. Cytometry Part Cytometry. 2018;93(9):941–951.
   Web of Science ®Google Scholar
• Ruan P, Tao Z, Tan A. Low expression of miR-30a-5p induced the proliferation and invasion of oral cancer via promoting the expression of FAP. Biosci Rep. 2018;38(1):BSR20171027.
   PubMed Web of Science ®Google Scholar
• Gong Q, Shi W, Li L, et al. Ultrasensitive fluorescent probes reveal an adverse action of dipeptide peptidase IV and fibroblast activation protein during proliferation of cancer cells. Anal Chem. 2016;88(16):8309–8314.
   PubMed Web of Science ®Google Scholar
• Kilvaer TK, Khanehkenari MR, Hellevik T, et al. Cancer associated fibroblasts in stage I-IIIA NSCLC: prognostic impact and their correlations with tumor molecular markers. PLoS One. 2015;10(8):e0134965.
   PubMed Web of Science ®Google Scholar
• Ariga N, Sato E, Ohuchi N, et al. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer. 2001;95(1):67–72.
   PubMed Web of Science ®Google Scholar
• Park H, Lee Y, Lee H, et al. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Tumour Biol. 2017;39(10):101042831771840.
   Google Scholar
• Siveke JT. Fibroblast-activating protein: targeting the roots of the tumor microenvironment. J Nucl Med. 2018;59(9):1412–1414.
   PubMed Web of Science ®Google Scholar